LU75535A1 - - Google Patents

Info

Publication number
LU75535A1
LU75535A1 LU75535A LU75535A LU75535A1 LU 75535 A1 LU75535 A1 LU 75535A1 LU 75535 A LU75535 A LU 75535A LU 75535 A LU75535 A LU 75535A LU 75535 A1 LU75535 A1 LU 75535A1
Authority
LU
Luxembourg
Application number
LU75535A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75535A1 publication Critical patent/LU75535A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU75535A 1975-08-05 1976-08-04 LU75535A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32659/75A GB1579120A (en) 1975-08-05 1975-08-05 Extracts of the haemopoietic system

Publications (1)

Publication Number Publication Date
LU75535A1 true LU75535A1 (fr) 1978-02-13

Family

ID=10342062

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75535A LU75535A1 (fr) 1975-08-05 1976-08-04

Country Status (19)

Country Link
US (1) US4294824A (fr)
JP (1) JPS5218807A (fr)
AR (1) AR211931A1 (fr)
AU (1) AU515950B2 (fr)
BE (1) BE844875A (fr)
CA (1) CA1063019A (fr)
DE (1) DE2635065C2 (fr)
DK (1) DK350876A (fr)
FI (1) FI762178A (fr)
FR (1) FR2320106A1 (fr)
GB (1) GB1579120A (fr)
IE (1) IE44378B1 (fr)
IN (1) IN144537B (fr)
IT (1) IT1062655B (fr)
LU (1) LU75535A1 (fr)
NL (1) NL7608651A (fr)
NZ (1) NZ181653A (fr)
SE (1) SE7608771L (fr)
ZA (1) ZA764643B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU182087B (en) * 1980-01-15 1983-12-28 Mta Kiserleti Orvostudomanyi K Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia
JPS6339609Y2 (fr) * 1980-11-21 1988-10-18
JPS59141520A (ja) * 1983-02-02 1984-08-14 Kyowa Hakko Kogyo Co Ltd Ｄｎａ合成抑制物質
US5711881A (en) * 1992-04-12 1998-01-27 Toray Industries, Inc. Hematopoietic inhibiting factor containing compositions
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
ATE268810T1 (de) * 1995-12-21 2004-06-15 Genzyme Corp Methode zur zellyse
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
ATE276356T1 (de) 1998-03-26 2004-10-15 Viranative Ab Verfahren zur kontinuierlichenaufreinigung und konzentrierung von leukozyten aus blut
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6664049B1 (en) * 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
EP1640012A1 (fr) * 2004-09-24 2006-03-29 Salama, Zoser B. nat.rer.Dr. Agents pharmaceutiques comprenant des constituants du sang 10 kDa et l'utilisation dans la prophylaxe et dans le traitement des troubles du système immunitaire
DE102004047262A1 (de) * 2004-09-24 2006-04-06 Ipss International Pharmaceutical Strategies & Solutions Pharmazeutisches Mittel umfassend Blutprodukte und deren Verwendung als Injektions- oder Infusionsmittel zur Prophylaxe und Behandlung von Defekten des Immunsystems beim Menschen
US20060067942A1 (en) * 2004-09-24 2006-03-30 Salama Zoser B Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals

Also Published As

Publication number Publication date
JPS5218807A (en) 1977-02-12
DE2635065C2 (de) 1983-10-27
IE44378B1 (en) 1981-11-04
IN144537B (fr) 1978-05-13
DK350876A (da) 1977-02-06
NZ181653A (en) 1979-01-11
CA1063019A (fr) 1979-09-25
DE2635065A1 (de) 1977-02-17
AU515950B2 (en) 1981-05-14
FR2320106B1 (fr) 1980-11-07
AR211931A1 (es) 1978-04-14
IT1062655B (it) 1984-10-20
GB1579120A (en) 1980-11-12
US4294824A (en) 1981-10-13
IE44378L (en) 1977-02-05
SE7608771L (sv) 1977-02-06
NL7608651A (nl) 1977-02-08
ZA764643B (en) 1978-03-29
FR2320106A1 (fr) 1977-03-04
BE844875A (fr) 1977-02-04
AU1661476A (en) 1978-02-09
FI762178A (fr) 1977-02-06

Similar Documents

Publication Publication Date Title
JPS5263327U (fr)
JPS51102962U (fr)
CH595131A5 (fr)
BG21318A1 (fr)
BG21347A1 (fr)
BG22103A1 (fr)
BG22116A1 (fr)
BG22147A1 (fr)
BG22295A1 (fr)
BG22652A1 (fr)
BG22771A1 (fr)
BG23058A1 (fr)
BG23247A1 (fr)
BG23431A1 (fr)
CH1426175A4 (fr)
CH574010A5 (fr)
CH575785A5 (fr)
CH582554A5 (fr)
CH584094A5 (fr)
CH584450A5 (fr)
CH585482A5 (fr)
CH585874A5 (fr)
CH586389A5 (fr)
CH586398A5 (fr)
CH587608A5 (fr)